Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular neoplasms: seminoma.

E K Reddy1, M Burke, S Giri

  • 1Department of Radiation Oncology, University of Kansas Medical Center, Kansas City 66103.

Journal of the National Medical Association
|September 1, 1990
PubMed
Summary

This study on testicular seminoma found high survival rates across all stages, with no significant differences based on histology or hCG levels. Radiation therapy was the primary treatment, showing good outcomes with no late complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Who stop telemonitoring disease activity and who adhere: a prospective cohort study of patients with inflammatory arthritis.

BMC rheumatology·2022
Same author

The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study.

Clinical rheumatology·2022
Same author

Pyrimidine-2,4-dione targets STAT3 signaling pathway to induce cytotoxicity in hepatocellular carcinoma cells.

Bioorganic & medicinal chemistry letters·2021
Same author

Extracellular matrix compression temporally regulates microvascular angiogenesis.

Science advances·2020
Same author

Tuberculous meningitis mimicking Creutzfeldt-Jakob disease.

Revue neurologique·2020
Same author

Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens.

Journal of viral hepatitis·2018

Area of Science:

  • Oncology
  • Urologic Oncology
  • Cancer Research

Background:

  • Testicular seminoma is a significant diagnosis in urologic oncology.
  • Understanding long-term outcomes and treatment efficacy is crucial for patient management.

Purpose of the Study:

  • To analyze the treatment outcomes and survival rates of testicular seminoma patients.
  • To evaluate the impact of histology and specific biomarkers on prognosis.

Main Methods:

  • Retrospective analysis of 58 testicular seminoma patients treated between 1969-1984.
  • Staging according to the American Joint Committee on Cancer Staging System.
  • Assessment of survival rates, treatment modalities (radiation, chemotherapy), and complications.

Main Results:

Related Experiment Videos

  • Overall disease-free survival varied by stage (Stage I: 91-100%, Stage II: 66-80%, Stage III: 75-85%, Stage IV: 50%).
  • Radiation therapy was administered to 56 patients; 7 received chemotherapy.
  • No significant difference in survival was observed for patients with anaplastic histology or elevated human chorionic gonadotropin (hCG) B subunit compared to typical seminoma.
  • No late complications were reported.

Conclusions:

  • Testicular seminoma demonstrates favorable survival rates, particularly with early-stage diagnosis.
  • Treatment approaches, primarily radiation, yielded good outcomes with minimal late toxicity.
  • Histological subtype and hCG levels did not significantly impact patient survival in this cohort.